Fleury SA
BOVESPA:FLRY3

Watchlist Manager
Fleury SA Logo
Fleury SA
BOVESPA:FLRY3
Watchlist
Price: 15.19 BRL 0.73%
Market Cap: 8.3B BRL

Profitability Summary

Fleury SA's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

Analyzing past growth in Revenue, Operating Income, and Net Income allows investors to assess the company's profitability and operational efficiency. Consistent improvement in these metrics typically signals long-term strength and stability.

Show More Less

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Show More Less

Earnings Waterfall
Fleury SA

Revenue
7.8B BRL
Cost of Revenue
-5.7B BRL
Gross Profit
2.1B BRL
Operating Expenses
-923.5m BRL
Operating Income
1.2B BRL
Other Expenses
-581m BRL
Net Income
606.2m BRL

Margins Comparison
Fleury SA Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
BR
Fleury SA
BOVESPA:FLRY3
8.3B BRL
27%
15%
8%
US
CVS Health Corp
NYSE:CVS
101.1B USD
14%
3%
0%
US
Cigna Corp
NYSE:CI
73.6B USD
10%
4%
2%
US
Cigna Group
XMUN:CGN
62.2B EUR
10%
4%
2%
DE
Fresenius SE & Co KGaA
XETRA:FRE
27.3B EUR
25%
10%
5%
DE
Fresenius Medical Care AG
XMUN:FME
23.2B EUR
25%
7%
4%
US
Laboratory Corporation of America Holdings
NYSE:LH
21.7B USD
28%
10%
6%
US
Quest Diagnostics Inc
NYSE:DGX
20.3B USD
33%
15%
9%
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.6B EUR
25%
7%
4%
US
Guardant Health Inc
NASDAQ:GH
12.9B USD
64%
-48%
-44%
US
DaVita Inc
NYSE:DVA
8.5B USD
32%
15%
6%
No Stocks Found

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Show More Less

Return on Capital Comparison
Fleury SA Competitors

Country Company Market Cap ROE ROA ROCE ROIC
BR
Fleury SA
BOVESPA:FLRY3
8.3B BRL
11%
5%
11%
9%
US
CVS Health Corp
NYSE:CVS
101.1B USD
1%
0%
7%
1%
US
Cigna Corp
NYSE:CI
73.6B USD
15%
4%
10%
6%
US
Cigna Group
XMUN:CGN
62.2B EUR
15%
4%
10%
6%
DE
Fresenius SE & Co KGaA
XETRA:FRE
27.3B EUR
6%
3%
7%
4%
DE
Fresenius Medical Care AG
XMUN:FME
23.2B EUR
5%
2%
5%
4%
US
Laboratory Corporation of America Holdings
NYSE:LH
21.7B USD
10%
5%
9%
6%
US
Quest Diagnostics Inc
NYSE:DGX
20.3B USD
14%
6%
11%
9%
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.6B EUR
5%
2%
5%
4%
US
Guardant Health Inc
NASDAQ:GH
12.9B USD
192%
-28%
-36%
-67%
US
DaVita Inc
NYSE:DVA
8.5B USD
-834%
4%
13%
10%
No Stocks Found

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

Show More Less